Association of VMAT2 gene polymorphisms with alcohol dependence

Journal of Neural Transmission

Volumn 120, Issue 8, 2013, Pages 1161-1169

  Fehr, Christoph ^a   Sommerlad, Daniel ^a   Sander, Thomas ^c   Anghelescu, Ion ^d   Dahmen, Norbert ^a   Szegedi, Armin ^e   Mueller, Christiana ^a   Zill, Peter ^f   Soyka, Michael ^f,g   Preuss, Ulrich W ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e MERCK RESEARCH LABORATORIES   (United States)

^f UNIVERSITY OF MUNICH   (Germany)

^g Private Hospital Meiringen   (Switzerland)

Author keywords

Alcoholism; Delirium; Genetics; SNP; VMAT2; Withdrawal

Indexed keywords

ALCOHOL; VESICULAR MONOAMINE TRANSPORTER 2;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ALLELE; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REWARD; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALCOHOLISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84881096616     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-0996-y     Document Type: Article

References (33)

1. APA (1994) Diagnostic and statistical manual of mental disorders, fourth edition (DSM IV). American Psychiatric Association, Washington
2. Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E, Fisher S, Fox L, Howells W, Bertelsen S, Hinrichs AL, Almasy L, Breslau N, Culverhouse RC, Dick DM, Edenberg HJ, Foroud T, Grucza RA, Hatsukami D, Hesselbrock V, Johnson EO, Kramer J, Krueger RF, Kuperman S, Lynskey M, Mann K, Neuman RJ, Nöthen MM, Nurnberger JIJR, Porjesz B, Ridinger M, Saccone NL, Saccone SF, Schuckit MA, Tischfield JA, Wang JC, Rietschel M, Goate AM, Rice JP, Gene, Environment Association Studies Consortium (2010) A genome-wide association study of alcohol dependence. Proc Natl Acad Sci USA 107:5082-5087
3. Bowirrat A, Oscar-Berman M (2005) Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet 132B:29-37
4. Dinwiddie SH, Reich T (1993) Genetic and family studies in psychiatric illness and alcohol and drug dependence. J Addict Dis 12:17-27
5. Ducci F, Goldman D (2008) Genetic approaches to addiction: genes and alcohol. Addiction 103:1414-1428
6. Erdfelder E, Faul F, Buchner A (1996) GPOWER: a general power analysis program. Behav Res Methods Instrum Comput 28:1-11
7. Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93:5166-5171
8. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ (2002) Selected major risk factors and global and regional burden of disease. Lancet 360:1347-1360
9. Fon EA, Pothos EN, Sun BC, Killeen N, Sulzer D, Edwards RH (1997) Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19:1271-1283
10. Gonzalez AM, Walther D, Pazos A, Uhl GR (1994) Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile. Brain Res Mol Brain Res 22:219-226
11. Hack LM, Kalsi G, Aliev F, Kuo PH, Prescott CA, Patterson DG, Walsh D, Dick DM, Riley BP, Kendler KS (2011) Limited associations of dopamine system genes with alcohol dependence and related traits in the Irish affected sib pair study of alcohol dependence (IASPSAD). Alcohol Clin Exp Res 35:376-385
12. Hall FS, Sora I, Uhl GR (2003) Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice. Neuropsychopharmacology 28:620-628
13. Harrington KA, Augood SJ, Kingsbury AE, Foster OJ, Emson PC (1996) Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease. Brain Res Mol Brain Res 36:157-162
14. Heath AC, Bucholz KK, Madden PA, Dinwiddie SH, Slutske WS, Bierut LJ, Statham DJ, Dunne MP, Whitfield JB, Martin NG (1997) Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol Med 27:1381-1396
15. Henry JP, Botton D, Sagne C, Isambert MF, Desnos C, Blanchard V, Raisman-Vozari R, Krejci E, Massoulie J, Gasnier B (1994) Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules. J Exp Biol 196:251-262
16. Johnson RG Jr (1988) Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. Physiol Rev 68:232-307
17. Lin Z, Walther D, Yu XY, Li S, Drgon T, Uhl GR (2005) SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism. Hum Mol Genet 14:1393-1404
18. Liu Y, Peter D, Roghani A, Schuldiner S, Prive GG, Eisenberg D, Brecha N, Edwards RH (1992) A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70:539-551
19. Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149
20. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546-1552
21. Pickel VM, Chan J, Nirenberg MJ (2002) Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Synapse 45:113-124
22. Prescott CA, Kendler KS (2001) Associations between marital status and alcohol consumption in a longitudinal study of female twins. J Stud Alcohol 62:589-604
23. Savelieva KV, Caudle WM, Miller GW (2006) Altered ethanol-associated behaviors in vesicular monoamine transporter heterozygote knockout mice. Alcohol 40:87-94
24. Scheurich A, Muller MJ, Wetzel H, Anghelescu I, Klawe C, Ruppe A, Lorch B, Himmerich H, Heidenreich M, Schmid G, Hautzinger M, Szegedi A (2000) Reliability and validity of the German version of the European addiction severity index (EuropASI). J Stud Alcohol 61:916-919
25. Schwab SG, Franke PE, Hoefgen B, Guttenthaler V, Lichtermann D, Trixler M, Knapp M, Maier W, Wildenauer DB (2005) Association of DNA polymorphisms in the synaptic vesicular amine transporter gene (SLC18A2) with alcohol and nicotine dependence. Neuropsychopharmacology 30:2263-2268
26. Selzer ML (1971) The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127:1653-1658
27. Sigvardsson S, Bohman M, Cloninger CR (1996) Replication of the Stockholm adoption study of alcoholism. Confirmatory cross-fostering analysis. Arch Gen Psychiatry 53:681-687
28. Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl GR (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci USA 94:9938-9943
29. Treutlein J, Rietschel M (2011) Genome-wide association studies of alcohol dependence and substance use disorders. Curr Psychiatry Rep 13:147-155
30. Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG (1997) Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19:1285-1296
31. WHO (2001) The world health report. Mental health: new understanding. New Hope, Geneve
32. Wittchen HU, Lachner G, Wunderlich U, Pfister H (1998) Test-retest reliability of the computerized DSM-IV version of the Munich-composite international diagnostic interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33:568-578
33. Xu W, Emson PC (1997) Neuronal stem cells express vesicular monoamine transporter 2 immunoreactivity in the adult rat. Neuroscience 76:7-10